Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€44.10

€44.10

0.680%
0.3
0.680%
-
 
24.04.24 / Tradegate WKN: 555060 / Name: Drägerwerk / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Drägerwerk AG & Co. KGaA ST Stock

Drägerwerk AG & Co. KGaA ST gained 0.680% compared to yesterday.
So far the community has only identified positive things for Drägerwerk AG & Co. KGaA ST stock. The most positive votes were given for criterium "Valuation (undervalued/overvalued)".

Pros and Cons of Drägerwerk AG & Co. KGaA ST in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Drägerwerk AG & Co. KGaA ST vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Drägerwerk AG & Co. KGaA ST 0.680% -0.451% -2.000% 9.975% -1.121% -37.535% 11.364%
Drägerwerk AG & Co. KGaA VZO -0.400% -0.198% 1.921% 10.526% -2.890% -32.800% 9.233%
Agfa Gevaert N.V. -3.000% -1.681% -8.594% -59.304% -19.643% -71.705% -69.845%
Ion Beam Applications S.A. -0.450% 1.991% 7.246% -19.175% 15.425% -25.084% -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-26

Upon initial observation of Drägerwerk's financial statements, it appears that the company has experienced some fluctuations in its performance over the years. As a leading company in the Healthcare Equipment & Supplies industry, understanding these financials will allow investors to make informed decisions.

Pros

Revenue Growth: The company's total revenue has increased steadily over the past three years, from €3,406,276,000 in 2020 to €3,450,520,000 in 2022, reflecting a positive growth trend.

Comments

systinvest hat das Wertpapier Drägerwerk AG & Co. KGaA ST in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more

Sell Drägerwerk AG & Co. KGaA ST
Show more

News

EQS-News: Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend